Suppr超能文献

克服肝素相关性 RT-qPCR 抑制和急性心肌梗死患者 microRNA 定量的标准化问题。

Overcoming Heparin-Associated RT-qPCR Inhibition and Normalization Issues for microRNA Quantification in Patients with Acute Myocardial Infarction.

机构信息

Institute of Genetic Medicine, Newcastle University, International Centre for Life, Newcastle upon Tyne, United Kingdom.

Department of Cardiology, Freeman Hospital, Newcastle upon Tyne NHS Foundation Trust, High Heaton, Newcastle upon Tyne, United Kingdom.

出版信息

Thromb Haemost. 2018 Jul;118(7):1257-1269. doi: 10.1055/s-0038-1660437. Epub 2018 Jun 11.

Abstract

BACKGROUND

Cardiac-enriched micro ribonucleic acids (miRNAs) are released into the circulation following ST-elevation myocardial infarction (STEMI). Lack of standardized approaches for reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) data normalization and presence of RT-qPCR inhibitors (e.g. heparin) in patient blood samples have prevented reproducible miRNA quantification in this cohort and subsequent translation of these biomarkers to clinical practice.

MATERIALS AND METHODS

Using a RT-qPCR miRNA screening platform, we identified and validated an endogenous circulating miRNA as a normalization control. In addition, we assessed the effects of in vivo and in vitro anticoagulant drugs administration (heparin and bivalirudin) on three RT-qPCR normalization strategies (global miRNA mean, exogenous spike-in control [cel-miR-39] and endogenous miRNA control). Finally, we evaluated the effect of heparin and its in vitro inhibition with heparinase on the quantification of cardiac-enriched miRNAs in STEMI patients.

RESULTS

miR-425-5p was validated as an endogenous miRNA control. Heparin administration in vitro and in vivo inhibited all RT-qPCR normalization strategies. In contrast, bivalirudin had no effects on cel-miR-39 or miR-425-5p quantification. In vitro RNA sample treatment with 0.3 U of heparinase overcame heparin-induced over-estimation of cardiac-enriched miRNA levels and improved their correlation with high-sensitivity troponin T.

CONCLUSION

miRNA quantification in STEMI patients receiving heparin is jeopardized by its effect on all RT-qPCR normalization approaches. Use of samples from bivalirudin-treated patients or in vitro treatment of heparin-contaminated samples with heparinase are suitable alternatives for miRNA quantification in this cohort. Finally, we reinforce the evidence that cardiac-enriched miRNAs early after myocardial reperfusion reflect the severity of cardiac injury.

摘要

背景

ST 段抬高型心肌梗死(STEMI)发生后,心脏丰富的 microRNA(miRNA)会被释放到循环系统中。由于缺乏标准化的逆转录定量实时聚合酶链反应(RT-qPCR)数据归一化方法,以及患者血液样本中存在 RT-qPCR 抑制剂(如肝素),因此无法在该队列中进行可重复的 miRNA 定量,也无法将这些生物标志物转化为临床实践。

材料和方法

我们使用 RT-qPCR miRNA 筛选平台,鉴定并验证了一种内源性循环 miRNA 作为归一化对照。此外,我们评估了体内和体外抗凝药物(肝素和比伐卢定)给药对三种 RT-qPCR 归一化策略(全局 miRNA 均值、外源性 Spike-in 对照[cel-miR-39]和内源性 miRNA 对照)的影响。最后,我们评估了肝素及其体外抑制物肝素酶对 STEMI 患者心脏丰富 miRNA 定量的影响。

结果

miR-425-5p 被验证为内源性 miRNA 对照。肝素的体内和体外给药均抑制了所有 RT-qPCR 归一化策略。相比之下,比伐卢定对 cel-miR-39 或 miR-425-5p 的定量没有影响。在 0.3 U 肝素酶的体外 RNA 样本处理中,克服了肝素诱导的心脏丰富 miRNA 水平的高估,并改善了它们与高敏肌钙蛋白 T 的相关性。

结论

接受肝素治疗的 STEMI 患者的 miRNA 定量受到肝素对所有 RT-qPCR 归一化方法的影响。使用比伐卢定治疗患者的样本或体外处理肝素污染样本的肝素酶是该队列中 miRNA 定量的合适替代方法。最后,我们加强了证据,表明心肌再灌注后早期的心脏丰富 miRNA 反映了心脏损伤的严重程度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验